Envista Holdings (NVST) Cost of Revenue (2018 - 2026)
Envista Holdings' (NVST) quarterly Cost of Revenue came in at $315.4 million in Q2 2026, up 12.28% year-on-year from $280.9 million in Q2 2025, and down 7.24% quarter-over-quarter from $340.0 million in Q4 2025.
Envista Holdings (NVST) Cost of Revenue (2018 - 2026) Analysis & Trends
Envista Holdings' Cost of Revenue history runs 9 years deep, the most recent figure standing at $315.4 million for Q2 2026.
- On a quarterly basis, Cost of Revenue rose 12.28% year-over-year to $315.4 million in Q2 2026; TTM through Apr 2026 was $1.3 billion, a 10.06% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 8.34% from the prior year.
- Cost of Revenue eased to $315.4 million in Q2 2026 per NVST's latest filing, from $340.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $340.0 million in Q4 2025 and bottomed at $257.3 million in Q2 2022.
- The 5-year median for Cost of Revenue is $283.7 million (2024), against an average of $288.6 million.
- Across the five-year window, Cost of Revenue dropped 9.46% in 2024 and increased 21.26% in 2025, its largest moves.
- Year by year, Cost of Revenue stood at $294.6 million in 2022, then increased by 5.13% to $309.7 million in 2023, then retreated by 9.46% to $280.4 million in 2024, then climbed by 21.26% to $340.0 million in 2025, then slipped by 7.24% to $315.4 million in 2026.
- Per Business Quant, the three latest NVST Cost of Revenue figures stand at $315.4 million (Q2 2026), $340.0 million (Q4 2025), and $299.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 2.56 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 18.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 5.51 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 532.58 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 11.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 303.50 Mn |
| 10 | Envista Holdings | 4.36 Bn | 3.28 Bn | 390.10 Mn | 315.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 315.40 Mn |
| Apr 3, 2026 | 315.40 Mn |
| Dec 31, 2025 | 340.00 Mn |
| Dec 31, 2025 | 340.00 Mn |
| Sep 26, 2025 | 299.70 Mn |
| Sep 26, 2025 | 299.70 Mn |
| Jun 27, 2025 | 312.20 Mn |
| Jun 27, 2025 | 312.20 Mn |
| Mar 28, 2025 | 280.90 Mn |
| Mar 28, 2025 | 280.90 Mn |
| Dec 31, 2024 | 280.40 Mn |
| Dec 31, 2024 | 280.40 Mn |
| Sep 27, 2024 | 283.70 Mn |
| Sep 27, 2024 | 283.70 Mn |
| Jun 28, 2024 | 306.50 Mn |
| Jun 28, 2024 | 306.50 Mn |
| Mar 29, 2024 | 267.30 Mn |
| Mar 29, 2024 | 267.30 Mn |
| Dec 31, 2023 | 309.70 Mn |
| Dec 31, 2023 | 309.70 Mn |